Orient EuroPharma Co., Ltd.
TWO: 4120.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mon-Lin Tsai
- Employees
- 339
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$4.0B
- Website
- https://www.oepgroup.com
Loading 4120…
Loading profile data…Frequently asked questions about 4120
What does Orient EuroPharma Co., Ltd. (4120.TWO) do?
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and...
Where does 4120.TWO trade?
Orient EuroPharma Co., Ltd. (4120.TWO) trades on the Taipei Exchange.
What sector is 4120.TWO in?
Orient EuroPharma Co., Ltd. (4120.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Orient EuroPharma Co., Ltd.?
Mon-Lin Tsai is the chief executive officer of Orient EuroPharma Co., Ltd. (4120.TWO).
Where is Orient EuroPharma Co., Ltd. headquartered?
Orient EuroPharma Co., Ltd. is headquartered in Taiwan.
Does 4120.TWO pay a dividend?
Yes — Orient EuroPharma Co., Ltd. (4120.TWO) paid a trailing twelve-month dividend of TWD 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4120.TWO go public?
Orient EuroPharma Co., Ltd. (4120.TWO) completed its initial public offering in 2007.